1 Topical application of the
bioflavonoid 4',5,7-trihydroxyflavone (apigenin) to mous
2 However, the activities of
bioflavonoids against the individual isoforms of human t
3 Bioflavonoids are agents with potential immunosuppressiv
4 Bioflavonoids are human dietary components that have bee
5 ssays, we demonstrated that ferulic acid and
bioflavonoids are indeed highly bactericidal to CLas, wi
6 Bioflavonoids are plant compounds touted for their poten
7 experiments demonstrated a religation of the
bioflavonoid as well as the VP16-induced MLL cleavage si
8 motivate the use of this and similar dietary
bioflavonoids as relatively nontoxic inhibitors of AhR a
9 Because
bioflavonoids block PAH-induced cell transformation and
10 Proanthocyanidins (PAs) are a group of
bioflavonoids consisting of oligomers based on catechin
11 Bioflavonoids do not require redox cycling for activity
12 successfully demonstrated the utility of the
bioflavonoid (-)-
EGCG, a natural product as a chiral sol
13 echanism of action of three major classes of
bioflavonoids,
flavones, flavonols, and isoflavones, aga
14 le the 4'-OH moiety contributes primarily to
bioflavonoid function.
15 These data support the hypothesis that
bioflavonoids function as topoisomerase II poisons in hu
16 Urinary HO-1 was higher in
bioflavonoid groups.
17 The
bioflavonoids hold promise as agents that can reduce imm
18 These
bioflavonoids improve early outcomes in cadaveric renal
19 PBE (a concentrate of water-soluble
bioflavonoids,
mainly including phenolic compounds) has
20 e results suggest that maternal ingestion of
bioflavonoids may induce MLL breaks and potentially tran
21 jects tasted and rated five solutions of the
bioflavonoid naringin in 4% sucrose.
22 ents inducing infant leukemia, we identified
bioflavonoids,
natural substances in food as well as in
23 ulating effects of several tea catechins and
bioflavonoids on DNA methylation catalyzed by prokaryoti
24 d the effects of quercetin and curcumin, two
bioflavonoids,
on ischemia-reperfusion in the rat.
25 use inhibition of beta-catenin with shRNA or
bioflavonoid quercetin prevents calcification in primary
26 The
bioflavonoids quercetin and curcumin are renoprotective
27 (-)-epigallocatechin-3-O-gallate (EGCG)] and
bioflavonoids (
quercetin, fisetin, and myricetin) inhibi
28 out both in the presence and absence of the
bioflavonoid,
quercetin.
29 Of seven
bioflavonoids screened, galangin (3,5,7-trihydroxyflavon
30 topoisomerase II (topo II) as the target of
bioflavonoids similar to VP16 and Dox.
31 Genistein was the most active
bioflavonoid tested and stimulated enzyme-mediated DNA c
32 Based on 20
bioflavonoids tested, we identified a common structure e
33 on was inhibited by apigenin, a nonmutagenic
bioflavonoid that has been shown to prevent mouse skin c
34 Bioflavonoid therapy improved early graft function.
35 Quercetin, a
bioflavonoid which inhibits the synthesis of hsp90, hsp7
36 Genistein, a widely consumed
bioflavonoid with chemopreventative properties in adults